No. of studies | 3 | 4 | 8 | 33 | 43 | 13 |
No. of patients | 191 | 146 | 680 | 2067 | 2900 | 1010 |
Age, mean ± SD, yr | 58.8 ± 1.8 | 61 ± 2.9 | 63.1 ± 3.7 | 61.1 ± 10.8 | 62.4 ± 4.3 | 63.1 ± 3.7 |
Primary cancer (n = 5728) |
Breast | 127 (66.7) | 96 (66.0) | 208 (30.6) | 775 (37.5) | 829 (28.6) | 290 (28.7) |
Renal | 11 (5.6) | 6 (4.1) | 338 (49.7) | 395 (19.1) | 412 (14.2) | 113 (11.2) |
Lung | 16 (8.6) | 14 (9.5) | 33 (4.9) | 258 (12.5) | 455 (15.7) | 217 (21.5) |
Prostate | 2 (1.2) | 5 (3.4) | 15 (2.2) | 194 (9.4) | 252 (8.7) | 53 (5.2) |
Multiple myeloma | 9 (4.9) | 10 (6.8) | 27 (3.9) | 153 (7.4) | 252 (8.7) | 70 (6.9) |
Thyroid | 6 (3.1) | 3 (2.0) | 0 (0.0) | 8 (0.4) | 52 (1.8) | 16 (1.6) |
Lymphoma | 0 (0.0) | 2 (1.4) | 6 (0.9) | 35 (1.7) | 35 (1.2) | 10 (1.0) |
Plasmocytoma | 0 (0.0) | 0 (0.0) | 0 (0.0) | 8 (0.4) | 3 (0.1) | 0 (0.0) |
Melanoma | 0 (0.0) | 0 (0.0) | 0 (0.0) | 66 (3.2) | 49 (1.7) | 1 (0.1) |
Gastrointestinal | 1 (0.6) | 2 (1.4) | 10 (1.4) | 27 (1.3) | 81 (2.8) | 34 (3.4) |
Liver | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (0.3) | 38 (1.3) | 45 (4.5) |
Other | 18 (9.3) | 8 (5.4) | 44 (6.5) | 143 (6.9) | 438 (15.1) | 161 (15.9) |
Bone involvement |
Femur | 138 (72.2) | 85 (58.4) | 566 (83.2) | 1554 (75.2) | 1876 (64.7) | 981 (97.1) |
Humerus | 53 (27.8) | 61 (41.6) | 110 (16.2) | 482 (23.3) | 998 (34.4) | 26 (2.6) |
Tibia | 0 (0.0) | 0 (0.0) | 4 (0.5) | 31 (1.5) | 26 (0.9) | 3 (0.3) |
Fixation method (n = 5856) |
Endoprosthesis | 34 (17.7) | 18 (12.1) | 134 (19.7) | 606 (29.3) | 1032 (35.6) | 243 (24.1) |
Arthroplasty | 49 (25.8) | 71 (48.3) | 31 (4.6) | 273 (13.2) | 261 (9.0) | 99 (9.8) |
Intramedullary nail | 30 (15.8) | 31 (21.5) | 283 (41.6) | 878 (42.5) | 1221 (42.1) | 550 (54.5) |
Open reduction and internal fixation | 78 (40.7) | 26 (18.1) | 232 (34.1) | 296 (14.3) | 255 (8.8) | 35 (3.5) |
Allograft prosthetic composite | 0 (0.0) | 0 (0.0) | 0 (0.0) | 14 (0.7) | 9 (0.3) | 0 (0.0) |
Cementoplasty | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 122 (4.2) | 83 (8.2) |